Fig. 2From: Analysis of the time-to-onset of osteonecrosis of jaw with bisphosphonate treatment using the data from a spontaneous reporting system of adverse drug eventsHistogram and Weibull shape parameter of BRONJ for (a) alendronate (Intravenous), (b) pamidronate, (c) zoledronate, (d) alendronate (oral), (e) etidronate, (f) minodronate and (g) risedronateBack to article page